{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T11:33:17Z","timestamp":1700739197823},"reference-count":20,"publisher":"The Japanese Society for Medical Mycology","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Mycology Journal"],"published-print":{"date-parts":[[2011]]},"DOI":"10.3314\/mmj.52.283","type":"journal-article","created":{"date-parts":[[2011,11,28]],"date-time":"2011-11-28T06:25:25Z","timestamp":1322461525000},"page":"283-289","source":"Crossref","is-referenced-by-count":5,"title":["Zygomycosis"],"prefix":"10.3314","volume":"52","author":[{"given":"Takeshi","family":"Mori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuriko","family":"Yahata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Tsukune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1842","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Trifilio SM, Bennett CL, Yarnold PR, McKoy JM, Parada J, Mehta J, Chamilos G, Palella F, Kennedy L, Mullane K, Tallman MS, Evans A, Scheetz MH, Blum W, Kontoyiannis DP: Breakthrough zygomycosis after voriconazole administration among patients with hematologic malig nancies who receive hematopoietic stem-cell trans plants or intensive chemotherapy. BMT 39: 425-429, 2007.","DOI":"10.1038\/sj.bmt.1705614"},{"key":"2","unstructured":"2) \u68ee \u5065\u307b\u304b:\u6295\u7a3f\u4e88\u5b9a."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Torres HA, Raad II, Kontoyiannis DP: Infections caused by Fusarium species. J Chemother 15: 28-35, 2003.","DOI":"10.1179\/joc.2003.15.Supplement-2.28"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00014-07"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Zimmerli W, Zarth A, Gratwohl A, Speck B: Neutrophil function and pyogenic infections in bone marrow transplant recipients. Blood 77: 393-399, 1991.","DOI":"10.1182\/blood.V77.2.393.bloodjournal772393"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Arai H, Katayama N, Yamashita Y, Mano H, Fujieda A, Usui E, Mitani H, Ohishi K, Nishii K, Masuya M, Minami N, Nobori T, Shuku H: Reprogramming of human postmitotic neutrophils into macrophages by growth factors. Blood 2004; 103: 2973-2980.","DOI":"10.1182\/blood-2003-08-2742"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Goodill JJ, Abuelo JG: Mucormycosis-a new risk of deferoxamine therapy in dialysis patients with alumininum or iron overload. N Engl J Med 317: 54, 1987.","DOI":"10.1056\/NEJM198707023170114"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) \u68ee \u5065,\u6c5f\u982d\u5143\u6a39,\u5ddd\u53c8\u7d00\u5f66,\u62bc\u5473\u548c\u592b,\u4e2d\u6751\u548c\u88d5,\u5c0f\u6817\u8c4a\u5b50,\u6703\u7530\u79c0\u5b50,\u665d\u9593\u660e\u5b50,\u4e00\u6238\u6b63\u52dd:\u63a5\u5408\u83cc\u75c7;2\u75c7\u4f8b\u306e\u5831\u544a\u304a\u3088\u3073\u672c\u90a6\u5831\u544a\u4f8b\u306e\u691c\u8a0e.\u771f\u83cc\u8a8c 44:163-179, 2003.","DOI":"10.2307\/4014216"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Inagaki N, Sugimoto K, Isobe Y, Yamamoto Y, Sasaki M, Kato A, Mori T, Oshimi K: Disseminated mucor infection and thrombotic microangiopathy in lymphoma-associated hemophagocytic syndrome. Int J Hematol 88(3):355-356, 2008.","DOI":"10.1007\/s12185-008-0156-6"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1080\/13693780500474327"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Kimura M, Yaguchi T, Sutton DA, Fothergill AW, Thompson EH, Wickes BL: Disseminated human Conidiobolomycosis due to Condiobolus lamprauges. J Clin Microbiol 49(2): 752-756, 2011.","DOI":"10.1128\/JCM.01484-10"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Pfaller MA, Messer SA, Hollis RJ, Jones RN, and the Sentry Participants Group: Antifungal activity of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole, amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi; report from SENTRY antifungal surveillance program, 2000. Antimicrob Agents Chemother, 1032-1037, 2002.","DOI":"10.1128\/AAC.46.4.1032-1037.2002"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Sun QN, Fothergill AW, McCarthy DI, Rinaldi MG, Graybill JR: In vitro activity of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole aginst 37 clinical isolates od zygomycetes. Antimicrob Agents Chemother 46: 1581-1582, 2002.","DOI":"10.1128\/AAC.46.5.1581-1582.2002"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Diekema DJ, Messer SA, Hollis RJ, Jones RN, Pfaller MA: Activities of caspofungin, itraconazole, posaconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi. J Clin Mocrobiol 41: 3623-3626, 2003.","DOI":"10.1128\/JCM.41.8.3623-3626.2003"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1086\/588475"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Reed C, Bryant R, Ibrahim A, Edwards J Jr, Filler SG, Goldberg R, Spellberg B: Combination polyen-caspofungin treatment of rhino-orbital-cerebral mucormycosiss. Clin Infect Dis 47: 364-371, 2008.","DOI":"10.1086\/589857"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Spellberg B, Walsh TJ, Kontoyiannis DP, Edwards J Jr, Ibrahim AS: Recent advances in the management of mucormycosis; from bench to bedside. Clin Infect Dis 48: 1743-1751, 2009.","DOI":"10.1086\/599105"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Galgóczy L, Nyilasi I, Papp T, et al: Are statins applicable for the prevention and treatment of zygomycosis? Clin Infect Dis 49: 483-484, 2009.","DOI":"10.1086\/600825"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Chmilos G, Lewis RE, Kontoyiannis DP: Lovastatin has significant activity against zygomycetes and interacts synergistically with voriconazole. Clin Infect Dis 50: 96-103, 2006.","DOI":"10.1128\/AAC.50.1.96-103.2006"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Chamilos G, Lewis RE, Kontoyiannis DP: Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis 47:503-509, 2008.","DOI":"10.1086\/590004"}],"container-title":["Medical Mycology Journal"],"original-title":[],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T17:33:09Z","timestamp":1621531989000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/mmj\/52\/4\/52_4_283\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.3314\/mmj.52.283","relation":{},"ISSN":["2185-6486","2186-165X"],"issn-type":[{"value":"2185-6486","type":"print"},{"value":"2186-165X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011]]}}}